Pelvic Floor Muscle Activity in Primary Dysmenorrhea
ConditionPrimary Dysmenorrhea
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age19-24
SponsorCairo University
About this trial
This study will be conducted to assess the pelvic floor muscle (PFM) activity in primary dysmenorrhea (PD).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
They should be virgin, healthy female physiotherapy students with PD.
They have regular menstruation (3-8 days in duration, with 21-35 days in between).
Their ages will range from 18 to 25 years old.
Their body mass index (BMI) will range from 18 to 24.9 kg/m2.
Disqualifiers
Any urological or gynecological disorders in the previous 12 weeks (e.g., endometriosis, fibroids).
Fibromyalgia.
Severe psychiatric or psychological disorders.
Those who had taken analgesics in the 12 hours before the assessment.
Trial population
Seventy-eight female physiotherapy students with PD will participate in this study. They will be selected randomly from the faculty of physical therapy at Cairo University.
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
No intervention
Other interventionNo intervention
Treatment groups
77 Participants
are divided into 3 treatment groupsGroup A: group of mild primary dysmenorrhea1 intervention
Group B: group of moderate primary dysmenorrhea1 intervention
Group C: group of severe primary dysmenorrhea1 intervention
Trial outcomes
Primary outcomes
1
Pelvic floor muscle (PFM) contraction
Transabdominal ultrasound (TAU) will be used to assess PFM contraction for all females ("cutting off the flow of urine mid-stream") in the three groups.
Time frame
1 month2
Pelvic floor muscle (PFM) relaxation
Transabdominal ultrasound (TAU) will be used to assess PFM relaxation during inspiration for all females.
Time frame
1 monthSecondary outcomes
1
Bladder section of the Australian Pelvic Floor Questionnaire
It will be used to assess the bladder symptoms of pelvic floor dysfunction for all females in the three groups. This section will be scored 0-45, with higher scores meaning more dysfunction
Time frame
1 month2
Bowel section of the Australian Pelvic Floor Questionnaire
It will be used to assess the bowel symptoms of pelvic floor dysfunction for all females in the three groups. This section will be scored 0-34, with higher scores meaning more dysfunction
Time frame
1 month3
36-Item Short Form Survey Instrument (SF-36)
The SF-36 questionnaire is a self-administered questionnaire containing 36 items. It measures health across eight multi-item dimensions, covering functional status, well-being, and overall health evaluation, each associated with 2-10 possible answers. The response to each question is extrapolated to a standardized set of answers, and the results are transferred to a scale of 0-100, where 0 represents the worst state of health and 100 represents the best state of health measured
Time frame
1 monthSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: